About Nanopharm
Nanopharm is a Healthcare company based in United Kingdom founded in 2002, and was acquired by Aptar in June 2019. Provider of analytical and product development solutions for orally inhaled and nasal drug products. Nanopharm offers products and services including OINDP Development Services, SmartTrack™, and Analytical Services. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Its legal entity is NANOPHARM LIMITED.
Company details
Nanopharm was founded in 2002 in the United Kingdom and operates in the pharmaceutical sector, focusing on orally inhaled and nasal drug products. Services encompass pre-formulation, formulation development, and analytical characterization from preclinical to clinical stages. Proprietary technologies such as CAB, INTERHALE, NANOPLEX, and DISSOHALE are utilized to support formulation processes. Clients including Janssen are served through these offerings.
- Headquarters United Kingdom
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website nanopharm.co.uk
- Social LinkedIn X YouTube
- Acquired by Aptar (Jun 2019)
- Legal Name Nanopharm Limited
- Date of Incorporation 11 Feb, 2002
- Jurisdiction LEEDS, ENGLAND
Products & Services of Nanopharm
Nanopharm offers a comprehensive portfolio of products and services, including OINDP Development Services, SmartTrack™, and Analytical Services.
Specialized support for nasal and inhaled drug product development
Proprietary system for bioequivalence demonstration without clinical studies
Comprehensive testing for drug stability and release in OINDP
Apps and channels of Nanopharm
its YouTube channel Aptar has 1.54K subscribers and 30 videos.
Videos from Nanopharm
The most watched videos on Nanopharm's YouTube channel, Aptar (1.54K subscribers). Click a video to play it here.
More on Aptar.
Investors in Nanopharm
Nanopharm has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Aptar.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Regulatory support, brand differentiation, and prototyping services are provided. | 1992 | aptar.com | Crystal Lake, United States |
Investor details for Nanopharm
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Nanopharm
2 dated milestones of Nanopharm across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Nanopharm is founded.
- Exit Acquired by Aptar.
Web traffic of Nanopharm
The website of Nanopharm (nanopharm.co.uk) receives about 2.3K visits a month.
- Monthly visits2.3K
▲ 48% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nanopharm
Complete news archive for Nanopharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nanopharm
Nanopharm was founded in 2002.
Nanopharm is headquartered in United Kingdom.
Nanopharm was founded in 2002 in the United Kingdom and operates in the pharmaceutical sector, focusing on orally inhaled and nasal drug products. Services encompass pre-formulation, formulation development, and analytical characterization from preclinical to clinical stages. Proprietary technologies such as CAB, INTERHALE, NANOPLEX, and DISSOHALE are utilized to support formulation processes. Clients including Janssen are served through these offerings.
Nanopharm offers OINDP Development Services, SmartTrack™, and Analytical Services.
Nanopharm has 1 investor. Key investors include Aptar.
Nanopharm operates through Nanopharm Limited.
Yes. Nanopharm was acquired by Aptar in June 2019.